Friday, July 31, 2026

K-POP Group RIIZE Hits Million Sales Milestone Twice!

According to the Hanteo Chart on June...

A SKY WRITTEN IN BLOOD : Deciphering The Deadly Trajectory Aimed At Michael DeSombre

North Korea launched unidentified projectiles into the East Sea, marking its first show of force in six weeks, raising regional tensions.

Heroic Helicopter Pilot Saves Thousands in North Korea Flood Rescue!

North Korea's Rodong Sinmun lauds Kim Myeon Hu, a helicopter squadron leader, for his heroic flood rescue, emphasizing exemplary leadership.

Tag: Mounjaro

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

Novo Nordisk sues Eli Lilly for misleading ads on obesity drugs, claiming false comparisons and seeking corrective action in court.

Teen Prescriptions for GLP-1 Obesity Drugs Surge in Korea, Raising Misuse Concerns

Surge in GLP-1 obesity treatment prescriptions among teens raises concerns over misuse and potential health risks.

Mounjaro prescriptions surge 12-fold in 8 months, surpassing 200,000 monthly for the first time

Mounjaro prescriptions surged over tenfold in eight months, raising concerns about access for patients with obesity amid rising cosmetic demand.

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.